{
    "clinical_study": {
        "@rank": "158254", 
        "arm_group": [
            {
                "arm_group_label": "Normal saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Continuous pump infusion of normal saline with  identical  volume, compared with  the low dose and high dose group,until 30 minutes before the end of surgery"
            }, 
            {
                "arm_group_label": "High dose group, dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "Continuous pump infusion  dexmedetomidine at 0.7 \u03bcg/kg/h until 30 minutes before the end of surgery"
            }, 
            {
                "arm_group_label": "Low dose  group, dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "Continuous pump infusion dexmedetomidine at 0.4 \u03bcg/kg/h  until 30 minutes before the end of surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to explore the effects of dexmedetomidine  on postoperative cognitive\n      dysfunction during one-lung ventilation in elder patients."
        }, 
        "brief_title": "Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Postoperative Confusion", 
        "condition_browse": {
            "mesh_term": [
                "Confusion", 
                "Cognition Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent.\n\n          -  Ongoing one-lung ventilation surgery.\n\n          -  American Society of Anesthesiologists class I to III.\n\n          -  Aged between 55 and 75 years old.\n\n          -  Body Mass Index between 18 and 25 kg/m2.\n\n        Exclusion Criteria:\n\n          -  Systolic blood pressure more than 180 mmHg or lower than 90 mmHg,diastolic blood\n             pressure  more than 110 mmHg or lower than 60 mmHg.\n\n          -  Serious heart,liver,kidney, pulmonary, and endocrine disease or serious infection.\n\n          -  Suspected or confirmed  difficult airway.\n\n          -  History of abnormal anesthesia.\n\n          -  Suspected of malignant hyperthermia.\n\n          -  Use of sedative and antidepressant drug  or  serious alcoholism\n\n          -  Mini-mental State Examination less than 17.\n\n          -  Highest academic degree below grade 6 in primary schools\n\n          -  Patients inability to exchange with serious visual and hearing impairment  or mental\n             disability.\n\n          -  History  of  shock.\n\n          -  Carotid artery stenosis and  central nervous system disease such as stroke, epilepsy.\n\n          -  Allergic to investigational products or with other contraindication.\n\n          -  Participated in other study within 30 days ."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "540", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02134093", 
            "org_study_id": "Tangdu sedation"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Normal saline", 
                    "High dose group, dexmedetomidine", 
                    "Low dose  group, dexmedetomidine"
                ], 
                "description": "Anesthesia induction:midazolam (0.03~0.05 mg/kg), fentanyl( 5~8 \u03bcg/kg), etomidate ( 0.15~0.2 mg/kg) and rocuronium(0.6mg/kg)", 
                "intervention_name": "Induction of anesthesia,midazolam ,fentanyl,etomidate and rocuronium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "High dose group, dexmedetomidine", 
                    "Low dose  group, dexmedetomidine"
                ], 
                "description": "Continuous pump infusion dexmedetomidine at 1\u03bcg/kg  over 10 minute\uff0cthen followed by a continuous pump infusion at 0.4 \u03bcg/kg/h\uff08low dose group\uff09or  0.7\u03bcg/kg/h until 30 minutes before the end of surgery.", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Normal saline", 
                "description": "Continuous pump infusion normal saline with identical volume of dexmedetomidine.", 
                "intervention_name": "Normal saline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Normal saline", 
                    "High dose group, dexmedetomidine", 
                    "Low dose  group, dexmedetomidine"
                ], 
                "description": "Continuous infusion of propofol \uff084~6 mg/kg/h\uff09, remifentanil \uff080.1~0.3 \u03bcg/kg/min\uff09is required to maintain the Bispectral Index within 40~60,Mean Arterial Blood Pressure more than 20% of baseline level , Oxygen Saturation more than 90% , airway pressure less than 40 cm H2O, intermittent injection vecuronium \uff080.05~0.1mg/kg\uff09 as needed to maintain muscle relaxation.", 
                "intervention_name": "Maintenance of anesthesia , propofol, remifentanil,vecuronium", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Midazolam", 
                "Etomidate", 
                "Fentanyl", 
                "Propofol", 
                "Remifentanil", 
                "Dexmedetomidine", 
                "Vecuronium Bromide", 
                "Rocuronium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "number_of_arms": "3", 
        "official_title": "Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients -a Single-center, Randomized ,Double-blinded and Controlled Trial", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The change  in learning  will be evaluated by Rey Auditory Verbal Learning Test", 
                "measure": "The change  in learning", 
                "safety_issue": "No", 
                "time_frame": "one day before operation , first day and seventh day  after operation"
            }, 
            {
                "description": "The change  in memory will be evaluated by Rey Auditory Verbal Learning Test,Controlled Oral Word Association Test ,Semantic Fluency test ,", 
                "measure": "The change  in memory", 
                "safety_issue": "No", 
                "time_frame": "one day before operation, first day and seventh day after operation"
            }, 
            {
                "description": "Cognitive function will be  evaluated by Mini-mentalStateExamination,Digit-Symbol Substitution Test ,Trail Making Test , Grooved Pegboard Dominant Hand", 
                "measure": "Cognitive function", 
                "safety_issue": "No", 
                "time_frame": "one day before operation, first day and seventh day after operation"
            }, 
            {
                "description": "Self-evaluation of Depression Symptoms form,Self-Rating Anxiety Scale,Visual analog scales", 
                "measure": "Postoperative anxiety", 
                "safety_issue": "No", 
                "time_frame": "one day before operation, first day and seventh day after operation"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02134093"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tang-Du Hospital", 
            "investigator_full_name": "YangLu", 
            "investigator_title": "physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Variation degree of Heart rate", 
                "safety_issue": "No", 
                "time_frame": "Prior to surgery\uff0cprior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation"
            }, 
            {
                "description": "Variation degree of airway pressure", 
                "measure": "Airway pressure", 
                "safety_issue": "No", 
                "time_frame": "Prior to surgery\uff0cprior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation"
            }, 
            {
                "measure": "Variation degree of blood gas analysis", 
                "safety_issue": "No", 
                "time_frame": "Prior to surgery\uff0cprior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation"
            }, 
            {
                "measure": "Bleeding volume", 
                "safety_issue": "No", 
                "time_frame": "At the beginning of surgery,at the end of surgery,up to 24 hours"
            }, 
            {
                "measure": "Total volume of  fluid", 
                "safety_issue": "No", 
                "time_frame": "At the beginning of surgery,at the end of surgery,up to 24 hours"
            }, 
            {
                "measure": "Duration of one lung ventilation", 
                "safety_issue": "No", 
                "time_frame": "At the beginning of one lung ventilation,at the end of one lung ventilation,an expected average of 3 hours"
            }, 
            {
                "measure": "Duration of  two-lung ventilations", 
                "safety_issue": "No", 
                "time_frame": "At the beginning of two-lung ventilations,at the end of two-lung ventilations, an expected average of  3 hours"
            }, 
            {
                "measure": "The total dose of  anaesthetic drugs", 
                "safety_issue": "No", 
                "time_frame": "At the beginning of surgery,at the end of surgery,up to 24 hours"
            }, 
            {
                "measure": "The total dose of analgesic drugs", 
                "safety_issue": "No", 
                "time_frame": "During perioperative period,up to 7 days"
            }, 
            {
                "measure": "Variation degree of  blood pressure", 
                "safety_issue": "No", 
                "time_frame": "Prior to surgery\uff0cprior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation"
            }, 
            {
                "measure": "Oxygen saturation", 
                "safety_issue": "No", 
                "time_frame": "Prior to surgery\uff0cprior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation"
            }, 
            {
                "measure": "End-tidal carbon dioxide", 
                "safety_issue": "No", 
                "time_frame": "Prior to surgery\uff0cprior to lung ventilation,10 minutes,30 minutes and 60 minutes afer lung ventilation,weaning,and postoperation"
            }
        ], 
        "source": "Tang-Du Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tang-Du Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}